DOCSLIB.ORG

How Dangerous Is Hyperkalemia?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
How Dangerous Is Hyperkalemia? BRIEF REVIEW www.jasn.org How Dangerous Is Hyperkalemia? † ‡ John R. Montford* and Stuart Linas* *Division of Renal Disease and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; †Renal Section, Medicine Service, Veterans Affairs Eastern Colorado Health System, Denver, Colorado; and ‡Division of Nephrology, Department of Medicine, Denver Health and Hospitals, Denver, Colorado ABSTRACT Hyperkalemia is a potentially life-threatening electrolyte disorder appreciated with lower the resting cardiac membrane po- greater frequency in patients with renal disease, heart failure, and with use of certain tential. This decreases the threshold for medications such as renin angiotensin aldosterone inhibitors. The traditional views rapid phase-0 Na+-dependent depolar- that hyperkalemia can be reliably diagnosed by electrocardiogram and that partic- ization resulting in an increase in cardiac ular levels of hyperkalemia confer cardiotoxic risk have been challenged by several conduction velocity.7 By electrocardio- reports of patients with atypic presentations. Epidemiologic data demonstrate gram (ECG), these changes are manifes- strong associations of morbidity and mortality in patients with hyperkalemia but ted by “peaked” or “tented” Twaves these associations appear disconnected in certain patient populations and in differ- most prominent in the precordial (V2– ing clinical presentations. Physiologic adaptation, structural cardiac disease, medi- V4) leads. With larger acute rises in ex- cation use, and degree of concurrent illness might predispose certain patients tracellular potassium concentration, presenting with hyperkalemia to a lower or higher threshold for toxicity. These conduction delay becomes prominent factors are often overlooked; yet data suggest that the clinical context in which in the atrioventricular node and His– hyperkalemia develops is at least as important as the degree of hyperkalemia is in Purkinje system due to action potential determining patient outcome. This review summarizes the clinical data linking shortening and prolongation of phase-4 hyperkalemia with poor outcomes and discusses how the efficacy of certain treat- diastolic depolarization.7,8 Indeed, pro- ments might depend on the clinical presentation. longation of the PR interval, P-wave am- plitude, and increased QRS complex J Am Soc Nephrol 28: 3155–3165, 2017. doi: https://doi.org/10.1681/ASN.2016121344 width are ominous findings in patients with advanced hyperkalemia that can precede a classically described “sine-wave” INTEGRATED DISCUSSION processes. Blunted potassium redistribu- pattern on ECG.9 Thus, hyperkalemia tion typically occurs through insulin predisposes to both cardiac hyperexcit- Introduction deficiency, decreases in aldosterone bio- ability (ventricular tachycardia, ventricular Hyperkalemia is an electrolyte distur- synthesis or action, diminished adrener- fibrillation) and depression (bradycardia, bance occurring with increased fre- gic signaling, and osmolar disturbances atrioventricular block, interventricular quency among patients with CKD, including hyperglycemia. Renal failure, conduction delay, and asystole), both of diabetes, heart failure, and use of certain and/or failure to augment distal tubular which can be fatal. medicationssuchasreninangiotensin potassium secretion, is largely respon- Despite a wealth of animal data dem- aldosterone system (RAAS) inhibitors sible for the maintenance of hyperkale- onstrating cardiotoxicity from acute and nonsteroidal anti-inflammatory mia. Many studies reproducibly identify hyperkalemia, these presentations are drugs.1–4 Extracellular potassium con- common clinical risk factors that are as- centration is usually kept within a narrow sociated with the development of hyper- physiologic range by redundant and kalemia regardless of the clinical setting Published online ahead of print. Publication date highly efficient homeostatic mechanisms (Table 1). available at www.jasn.org. that simultaneously control internal po- The fatal consequences of rapid in- Correspondence: Dr. John R. Montford, Division of tassium redistribution while regulating creases in extracellular potassium con- Renal Disease and Hypertension, University of Colorado Anschutz Medical Campus, Research 2, net potassium excretion. Hyperkalemia centration have been demonstrated in Box C281, 12700 E. 19th Avenue, Aurora, CO 80045. occurs when rises in extracellular potas- the setting of acute intravenous potas- Email: [email protected] 5,6 sium concentration are accompanied by sium loading in animals. Early rises Copyright © 2017 by the American Society of one, or additive, defects in these two in extracellular potassium concentration Nephrology J Am Soc Nephrol 28: 3155–3165, 2017 ISSN : 1046-6673/2811-3155 3155 BRIEF REVIEW www.jasn.org Table 1. Risk factors for the degrees of hyperkalemia and only ap- to 7.32). Furthermore, as compared development of hyperkalemia proached minimal predictive power with survivors with hyperkalemia, Clinical Risk Factor Medication Exposure with potassium levels of 7.2–9.4 meq/ nonsurvivors had higher increases in se- 17 6 Male sex Potassium supplements L. In patients on hemodialysis with hy- rum potassium preceding death (1.1 Non-black Penicillin G perkalemia, ECG-diagnosed T wave 1.3 versus 2.261.5 meq/L change in DM Digoxin “tenting” did not predict the serum serum potassium from admission, re- CVD NSAIDs potassium and substantially lost its sen- spectively). Most cases of hyperkalemia CHF ACEi/ARBs sitivity with increasing patient age and developed during hospitalization (in AKI MRAs presence of diabetes.18 Specificity for hy- 60% of the cohort) with a mean admis- CKD b-adrenergic blockers perkalemia and sudden death at follow- sion potassium level of 5.761.5 meq/L Acidosis Heparin up was improved with evaluation of the rising to 7.160.7 meq/L after an aver- Urinary obstruction Amiloride, Triamterene T:R wave amplitude in these patients, but ageof17daysoffollow-up. Trimethoprim, sensitivity was also diminished. In another retrospective review of Pentamidine Hyperkalemia has also been associ- .39,000 patients admitted to the inten- DM, diabetes mellitus; CVD, cardiovascular disease; NSAIDs, nonsteroidal anti-inflammatory ated with a host of nontraditional ECG sive care unit at two teaching hospitals in drugs; CHF, congestive heart failure; ACEi, changes including T wave inversions19 Boston, Massachusetts between 1997 angiotensin-converting enzyme inhibitor; ARB, and pseudonormalizations,20 bundle and 2007, incident hyperkalemia inde- angiotensin receptor blockade. branch,21 bifascicular,22 sinoatrial pendently predicted mortality at the exit,20 andatypicbundlebranch time of critical care initiation.32 This as- overall uncommon in humans. Reports blocks,8 and ST depressions and eleva- sociation was graded, with even minor of acute hyperkalemia precipitating car- tions.15,23,24 There are even reports of elevations in serum potassium (to levels diac arrest typically involve intravenous profound hyperkalemia with minimal 4.5–5.0 meq/L) conferring an increased potassium loading, massive cell turnover, or no discernable ECG changes.21,25,26 risk of death (OR for death within 30 or shift of potassium in the setting of Additionally, metabolic acidosis,27 left days, 1.49; 95% CI, 1.38 to 1.59), and 10–14 surgical anesthesia or critical illness. ventricular hypertrophy,28 early benign remained significant after adjusting for In these cases, the measured potas- repolarization,29 and acute coronary is- many potential confounders prevalent sium concentration was usually normal chemia30 are known to induce T wave in the critical care setting (adjusted OR, shortly before cardiopulmonary arrest; “tenting” in patients with normal serum 1.18; 95% CI, 1.09 to 1.27). Further- and only with rapid increases in serum potassium. Because there are currently more, failure of serum potassium to cor- fi potassium did the ndings of tachy- and inconsistent data supporting the utility rect by .1.0 meq/L within 48 hours after bradyarrhythmias associated with hy- of the ECG in predicting the degree of, initial measurement continued to pre- perkalemia become apparent. These and prognosis with, hyperkalemia, we dict death; whereas, this association extreme situations constitute a small must turn to published data that exam- was attenuated among patients achiev- minority of clinical hyperkalemia in ines the relationship between hyperkale- ing this degree of correction. Khanagavi humans which is often incidental, mia and cardiovascular outcomes. et al.33 reported on hospitalized patients asymptomatic, and of unknown duration. with serum potassium .5.1 meq/L, Additionally, there are many published Hyperkalemia in the Setting of finding that duration of hyperkalemia reports demonstrating a large disconnect Critical Illness and mortality increased substantially between degree of hyperkalemia and ex- Compelling data link hyperkalemia with with concomitant tissue necrosis [haz- pected ECG findings in humans. heightened adverse outcomes in the crit- ard ratio (HR) for death, 4.55; 95% CI, The ECG was observed to be some- ically ill population. In a retrospective 1.74 to 11.90], metabolic acidosis (HR, what unreliable in older studies of pa- analysis of 932 hospitalized adults in 4.84; 95% CI, 1.48 to 15.82), and AKI tients with potassium levels ,6.5 meq/ two Korean medical centers, high rates (HR, 3.89; 95% CI, 1.14 to 13.26). Total L.9,15 Modern studies and case reports of arrhythmia
Load more

Recommended publications
  • Early Manifestation of Calcinosis Cutis in Pseudohypoparathyroidism Type
    European Journal of Endocrinology (2005) 152 515–519 ISSN 0804-4643 CASE REPORT Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene Felix G Riepe, Wiebke Ahrens1, Nils Krone, Regina Fo¨lster-Holst2, Jochen Brasch2, Wolfgang G Sippell, Olaf Hiort1 and Carl-Joachim Partsch3 Department of Pediatrics, Division of Pediatric Endocrinology, Universita¨tsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universita¨t, 24105 Kiel, Germany, 1Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, Universita¨tsklinikum Schleswig-Holstein, Campus Lu¨beck, Universita¨t zu Lu¨beck, 23538 Lu¨beck, Germany, 2Department of Dermatology, Universita¨tsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universita¨t, 24105 Kiel, Germany and 3Children’s Hospital, Sta¨dtische Kliniken Esslingen, 73730 Esslingen a.N., Germany (Correspondence should be addressed to W G Sippell; Email: [email protected]) Abstract Objective: To clarify the molecular defect for the clinical finding of congenital hypothyroidism com- bined with the manifestation of calcinosis cutis in infancy. Case report: The male patient presented with moderately elevated blood thyrotropin levels at neonatal screening combined with slightly decreased plasma thyroxine and tri-iodothyronine concentrations, necessitating thyroid hormone substitution 2 weeks after birth. At the age of 7 months calcinosis cutis was seen and the patient underwent further investigation. Typical features of Albright’s heredi- tary osteodystrophy (AHO), including round face, obesity and delayed psychomotor development, were found. Methods and results: Laboratory investigation revealed a resistance to parathyroid hormone (PTH) with highly elevated PTH levels and a reduction in adenylyl cyclase-stimulating protein (Gsa) activity leading to the diagnosis of pseudohypoparathyroidism type Ia (PHP Ia).
    [Show full text]
  • Tumoral Calcinosis and Calciphylaxis Treated with Subtotal Parathyroidectomy and Sodium Thiosulphate
    CASE REPORT eISSN 2384-0293 Yeungnam Univ J Med 2016;33(1):68-71 http://dx.doi.org/10.12701/yujm.2016.33.1.68 Tumoral calcinosis and calciphylaxis treated with subtotal parathyroidectomy and sodium thiosulphate Hyunjeong Cho1, Yongjin Yi1, Eunjeong Kang1, Seokwoo Park1, Eun Jin Cho2, Sung Tae Cho3, Rho Won Chun3, Kyu Eun Lee4, Kook-Hwan Oh1 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul; 2Department of Internal Medicine, Hongseong Medical Center, Hongseong; 3Dr. Chun & Cho`s Medical Clinic & Dialysis Center; 4Department of Surgery, Seoul National University College of Medicine, Seoul, Korea Tumoral calcinosis (TC) is a condition resulting from extensive calcium phosphate precipitation, primarily in the periarticular tissues around major joints. Calciphylaxis is a fatal ischemic vasculopathy mainly affecting dermal blood vessels and subcutaneous fat. This syndrome is rare and predominantly occurs in patients with end-stage renal disease. Here, we report on a rare case involving a patient with TC complicated with calciphylaxis. Our patient was a 31-year-old man undergoing hemodialysis who presented with masses on both shoulders and necrotic cutaneous ulcers, which were associated with secondary hyperparathyroidism, on his lower legs. He underwent subtotal parathyroidectomy, and sodium thiosulfate (STS) was administered for 27 weeks. Twenty months after beginning the STS treatment course, he experienced dramatic relief of his TC and calciphylaxis. Keywords: Tumoral calcinosis; Calciphylaxis; Parathyroidectomy; Sodium thiosulphate INTRODUCTION reported to range from 0.5-3% [2]. The pathomechanisms of these two disorders are poorly understood, but believed to Calcinosis cutis is characterized by the deposition of in- be related to disturbances in mineral metabolism.
    [Show full text]
  • 1 Fluid and Elect. Disorders of Serum Sodium Concentration
    DISORDERS OF SERUM SODIUM CONCENTRATION Bruce M. Tune, M.D. Stanford, California Regulation of Sodium and Water Excretion Sodium: glomerular filtration, aldosterone, atrial natriuretic factors, in response to the following stimuli. 1. Reabsorption: hypovolemia, decreased cardiac output, decreased renal blood flow. 2. Excretion: hypervolemia (Also caused by adrenal insufficiency, renal tubular disease, and diuretic drugs.) Water: antidiuretic honnone (serum osmolality, effective vascular volume), renal solute excretion. 1. Antidiuresis: hyperosmolality, hypovolemia, decreased cardiac output. 2. Diuresis: hypoosmolality, hypervolemia ~ natriuresis. Physiologic changes in renal salt and water excretion are more likely to favor conservation of normal vascular volume than nonnal osmolality, and may therefore lead to abnormalities of serum sodium concentration. Most commonly, 1. Hypovolemia -7 salt and water retention. 2. Hypervolemia -7 salt and water excretion. • HYFERNATREMIA Clinical Senini:: Sodium excess: salt-poisoning, hypertonic saline enemas Primary water deficit: chronic dehydration (as in diabetes insipidus) Mechanism: Dehydration ~ renal sodium retention, even during hypernatremia Rapid correction of hypernatremia can cause brain swelling - Management: Slow correction -- without rapid administration of free water (except in nephrogenic or untreated central diabetes insipidus) HYPONA1REMIAS Isosmolar A. Factitious: hyperlipidemia (lriglyceride-plus-plasma water volume). B. Other solutes: hyperglycemia, radiocontrast agents,. mannitol.
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • Section XI Extraskeletal (Ectopic) Calcification and Ossification
    Section XI Extraskeletal (Ectopic) Calcification and Ossification Michael P. Whyte Division of Bone and Mineral Diseases, Washington University School of Medicine at Barnes-Jewish Hospital and Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children, St. Louis, Missouri INTRODUCTION somewhat higher value because they have greater serum phos- phate concentrations compared with adults. However, this is A significant number and variety of disorders cause extraskel- not well established.(5) etal deposition of calcium and phosphate (Table 1). In some, The material that comprises metastatic calcification may be mineral is precipitated as amorphous calcium phosphate or as amorphous calcium phosphate initially, but hydroxyapatite is crystals of hydroxyapatite; in others, osseous tissue is formed. deposited soon after.(2) The anatomic pattern of deposition The pathogenesis of ectopic mineralization is generally attrib- varies somewhat between hypercalcemia and hyperphos- uted to one of three mechanisms (Table 1). First, a supranormal phatemia, but occurs irrespective of the specific underlying “calcium-phosphate solubility product” in extracellular fluid condition or mechanism for the disturbed mineral homeostasis. can cause metastatic calcification. Second, mineral may be Additionally, there is a predilection for certain tissues. deposited as dystrophic calcification into metabolically im- Hypercalcemia is typically associated with mineral deposits paired or dead tissue despite normal serum levels of calcium in the kidneys, lungs, and fundus of the stomach. In these and phosphate. Third, ectopic ossification (or true bone forma- “acid-secreting” organs, a local alkaline milieu may account tion) occurs in a few disorders for which the pathogenesis is for the calcium deposition. In addition, the media of large becoming increasingly understood.
    [Show full text]
  • Hyperkalemia Masked by Pseudo-Stemi Infarct Pattern and Cardiac Arrest Shareez Peerbhai1 , Luke Masha2, Adrian Dasilva-Deabreu1 and Abhijeet Dhoble1,2*
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Peerbhai et al. International Journal of Emergency Medicine (2017) 10:3 International Journal of DOI 10.1186/s12245-017-0132-0 Emergency Medicine CASEREPORT Open Access Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest Shareez Peerbhai1 , Luke Masha2, Adrian DaSilva-DeAbreu1 and Abhijeet Dhoble1,2* Abstract Background: Hyperkalemia is a common electrolyte abnormality and has well-recognized early electrocardiographic manifestations including PR prolongation and symmetric T wave peaking. With severe increase in serum potassium, dysrhythmias and atrioventricular and bundle branch blocks can be seen on electrocardiogram. Although cardiac arrest is a worrisome consequence of untreated hyperkalemia, rarely does hyperkalemia electrocardiographically manifest as acute ischemia. Case presentation: We present a case of acute renal failure complicated by malignant hyperkalemia and eventual ventricular fibrillation cardiac arrest. Recognition of this disorder was delayed secondary to an initial ECG pattern suggesting an acute ST segment elevation myocardial infarction (STEMI). Emergent coronary angiography performed showed no evidence of coronary artery disease. Conclusions: Pseudo-STEMI patterns are rarely seen in association with acute hyperkalemia and are most commonly described with patient without acute cardiac symptomatology. This is the first such case presenting concurrently with cardiac arrest. A brief review of this rare pseudo-infarct pattern is also given. Keywords: Cardiac arrest, Hyperkalemia, Myocardial infarction, STEMI, ECG Background Case presentation Hyperkalemia that manifests with electrocardiographic A 27-year-old Caucasian male with a past medical his- findings of an ST segment elevation myocardial infarc- tory of hypertension presented to the emergency room tion (STEMI) is very rare.
    [Show full text]
  • Parenteral Nutrition Primer: Balance Acid-Base, Fluid and Electrolytes
    Parenteral Nutrition Primer: Balancing Acid-Base, Fluids and Electrolytes Phil Ayers, PharmD, BCNSP, FASHP Todd W. Canada, PharmD, BCNSP, FASHP, FTSHP Michael Kraft, PharmD, BCNSP Gordon S. Sacks, Pharm.D., BCNSP, FCCP Disclosure . The program chair and presenters for this continuing education activity have reported no relevant financial relationships, except: . Phil Ayers - ASPEN: Board Member/Advisory Panel; B Braun: Consultant; Baxter: Consultant; Fresenius Kabi: Consultant; Janssen: Consultant; Mallinckrodt: Consultant . Todd Canada - Fresenius Kabi: Board Member/Advisory Panel, Consultant, Speaker's Bureau • Michael Kraft - Rockwell Medical: Consultant; Fresenius Kabi: Advisory Board; B. Braun: Advisory Board; Takeda Pharmaceuticals: Speaker’s Bureau (spouse) . Gordon Sacks - Grant Support: Fresenius Kabi Sodium Disorders and Fluid Balance Gordon S. Sacks, Pharm.D., BCNSP Professor and Department Head Department of Pharmacy Practice Harrison School of Pharmacy Auburn University Learning Objectives Upon completion of this session, the learner will be able to: 1. Differentiate between hypovolemic, euvolemic, and hypervolemic hyponatremia 2. Recommend appropriate changes in nutrition support formulations when hyponatremia occurs 3. Identify drug-induced causes of hypo- and hypernatremia No sodium for you! Presentation Outline . Overview of sodium and water . Dehydration vs. Volume Depletion . Water requirements & Equations . Hyponatremia • Hypotonic o Hypovolemic o Euvolemic o Hypervolemic . Hypernatremia • Hypovolemic • Euvolemic • Hypervolemic Sodium and Fluid Balance . Helpful hint: total body sodium determines volume status, not sodium status . Examples of this concept • Hypervolemic – too much volume • Hypovolemic – too little volume • Euvolemic – normal volume Water Distribution . Total body water content varies from 50-70% of body weight • Dependent on lean body mass: fat ratio o Fat water content is ~10% compared to ~75% for muscle mass .
    [Show full text]
  • Electrolyte Disorders and Arrhythmogenesis
    Cardiology Journal 2011, Vol. 18, No. 3, pp. 233–245 Copyright © 2011 Via Medica REVIEW ARTICLE ISSN 1897–5593 Electrolyte disorders and arrhythmogenesis Nabil El-Sherif1, Gioia Turitto2 1State University of NY, Downstate Medical Center and NY Harbor VA Healthcare System, Brooklyn, NY, USA 2Methodist University Hospital, Brooklyn, NY, USA Abstract Electrolyte disorders can alter cardiac ionic currents kinetics and depending on the changes can promote proarrhythmic or antiarrhythmic effects. The present report reviews the mecha- nisms, electrophysiolgical (EP), electrocardiographic (ECG), and clinical consequences of elec- trolyte disorders. Potassium (K+) is the most abundent intracellular cation and hypokalemia is the most commont electrolyte abnormality encountered in clinical practice. The most signifcant ECG manifestation of hypokalemia is a prominent U wave. Several cardiac and + non cardiac drugs are known to suppress the HERG K channel and hence the IK, and especially in the presence of hypokalemia, can result in prolonged action potential duration and QT interval, QTU alternans, early afterdepolarizations, and torsade de pointes ventricu- lar tachyarrythmia (TdP VT). Hyperkalemia affects up to 8% of hospitalized patients mainly in the setting of compromised renal function. The ECG manifestation of hyperkalemia de- pends on serum K+ level. At 5.5–7.0 mmol/L K+, tall peaked, narrow-based T waves are seen. At > 10.0 mmol/L K+, sinus arrest, marked intraventricular conduction delay, ventricular techycardia, and ventricular fibrillation can develop. Isolated abnormalities of extracellular calcium (Ca++) produce clinically significant EP effects only when they are extreme in either direction. Hypocalcemia, frequently seen in the setting of chronic renal insufficiency, results in prolonged ST segment and QT interval while hypercalcemia, usually seen with hyperparathy- roidism, results in shortening of both intervals.
    [Show full text]
  • Case Report Calcinosis Cutis Associated with Chronic Sclerodermoid Graft Versus Host Disease: a Case and Review of the Literature
    Hindawi Case Reports in Dermatological Medicine Volume 2020, Article ID 9250923, 4 pages https://doi.org/10.1155/2020/9250923 Case Report Calcinosis Cutis Associated with Chronic Sclerodermoid Graft versus Host Disease: A Case and Review of the Literature Jacqueline Deen , Lisa Byrom, and Ivan Robertson Department of Dermatology, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia Correspondence should be addressed to Jacqueline Deen; [email protected] Received 11 December 2019; Revised 23 January 2020; Accepted 5 February 2020; Published 28 February 2020 Academic Editor: Alireza Firooz Copyright © 2020 Jacqueline Deen et al. )is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We present a rare case of calcinosis cutis associated with chronic sclerodermoid graft versus host disease in a 59-year-old male, 13 years following allogenic bone marrow transplantation. )e etiology of calcification was thought to be dystrophic. Further research is needed to understand the link between calcinosis cutis and chronic sclerodermoid graft versus host disease to assist with selecting appropriate management for these patients. 1. Introduction occurs from the deposition of calcium salts in the skin secondary to medical interventions, typically intravenous Calcinosis cutis is a descriptive term for the deposition of calcium gluconate and calcium chloride. Idiopathic calci- insoluble calcium salts in the dermis and subcutaneous fication occurs in the absence of an underlying tissue injury tissue and is associated with a number of underlying or metabolic disorder. )e final subtype, calciphylaxis, is a disorders.
    [Show full text]
  • Calcinosis Cutis,Calcinosis Circumscripta,And “Mille Feuille
    Calcinosis Cutis, Calcinosis Circumscripta, and “Mille Feuille” Lesions James Yi-Chien Lin, DVM MS; Han-Ju Tsai, DVM MS; Kau-Shen Hsu, DVM; Fun-In Wang, DVM PhD Skin and subcutaneous lesions of 2 cases with natural occurring Cushing’s disease and 1 case with calcinosis circumscripta were compared. Case 1 was typical of osteoma cutis, containing somewhat regularly arranged discrete ossification foci in the mid and deep dermis. Case 2 had layers of “mille feuille”, yellowish to white gritty chalky substances diffusely scattered in the sub- cutis, seen histologically as disseminatedly scattered light purple crystalloid and blue granular mineral salts. Lesions stained orange red with Alizarin Red S indicated the presence of calcium ions. Discrete ossification foci in the deep dermis and early multifocal collagenolysis with mine- ralization were also noted. Case 3 was typical of calcinosis circumscripta, seen grossly as yel- lowish chalky substance in both dermis and subcutis, and histologically as lakes of well- circumscribed light purple crystals and granular deep blue mineral salts. Case 2 had features of calcinosis cutis such as ossification foci and early multifocal collagenolysis. Case 2 also had “mille feuille” that was histologically similar to those mineral salts in case 3, but was not circum- scribed, and was not exactly calcinosis universalis. The component in case 1 was most likely hydroxyapatite Ca10(PO4)6(OH)2; the “mille feuille” of case 2 was most likely “calcium soap” after panniculitis and fat necrosis; and that in case 3 was most likely calcium phosphate CaPO4. Lo- cal factors, such as fluid exudation reflecting how well the inflammation was controlled clinically, may influence the wound healing, and thus the outcome of lesions.
    [Show full text]
  • Role of Phosphate in Biomineralization
    Henry Ford Health System Henry Ford Health System Scholarly Commons Endocrinology Articles Endocrinology and Metabolism 7-25-2020 Role of Phosphate in Biomineralization Sanjay Kumar Bhadada Sudhaker D. Rao Henry Ford Health System, [email protected] Follow this and additional works at: https://scholarlycommons.henryford.com/endocrinology_articles Recommended Citation Bhadada SK, and Rao SD. Role of Phosphate in Biomineralization. Calcif Tissue Int 2020. This Article is brought to you for free and open access by the Endocrinology and Metabolism at Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Endocrinology Articles by an authorized administrator of Henry Ford Health System Scholarly Commons. Calcifed Tissue International https://doi.org/10.1007/s00223-020-00729-9 REVIEW Role of Phosphate in Biomineralization Sanjay Kumar Bhadada1 · Sudhaker D. Rao2,3 Received: 31 March 2020 / Accepted: 14 July 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020 Abstract Inorganic phosphate is a vital constituent of cells and cell membranes, body fuids, and hard tissues. It is a major intracel- lular divalent anion, participates in many genetic, energy and intermediary metabolic pathways, and is important for bone health. Although we usually think of phosphate mostly in terms of its level in the serum, it is needed for many biological and structural functions of the body. Availability of adequate calcium and inorganic phosphate in the right proportions at the right place is essential for proper acquisition, biomineralization, and maintenance of mass and strength of the skeleton. The three specialized mineralized tissues, bones, teeth, and ossicles, difer from all other tissues in the human body because of their unique ability to mineralize, and the degree and process of mineralization in these tissues also difer to suit the specifc functions: locomotion, chewing, and hearing, respectively.
    [Show full text]
  • Medical Term Lay Term(S)
    MEDICAL TERM LAY TERM(S) ABDOMINAL Pertaining to body cavity below diaphragm which contains stomach, intestines, liver, and other organs ABSORB Take up fluids, take in ACIDOSIS Condition when blood contains more acid than normal ACUITY Clearness, keenness, esp. of vision - airways ACUTE New, recent, sudden ADENOPATHY Swollen lymph nodes (glands) ADJUVANT Helpful, assisting, aiding ADJUVANT Added treatment TREATMENT ANTIBIOTIC Drug that kills bacteria and other germs ANTIMICROBIAL Drug that kills bacteria and other germs ANTIRETROVIRAL Drug that inhibits certain viruses ADVERSE EFFECT Negative side effect ALLERGIC REACTION Rash, trouble breathing AMBULATE Walk, able to walk -ATION -ORY ANAPHYLAXIS Serious, potentially life threatening allergic reaction ANEMIA Decreased red blood cells; low red blood cell count ANESTHETIC A drug or agent used to decrease the feeling of pain or eliminate the feeling of pain by general putting you to sleep ANESTHETIC A drug or agent used to decrease the feeling of pain or by numbing an area of your body, local without putting you to sleep ANGINA Pain resulting from insufficient blood to the heart (ANGINA PECTORIS) ANOREXIA Condition in which person will not eat; lack of appetite ANTECUBITAL Area inside the elbow ANTIBODY Protein made in the body in response to foreign substance; attacks foreign substance and protects against infection ANTICONVULSANT Drug used to prevent seizures ANTILIPIDEMIC A drug that decreases the level of fat(s) in the blood ANTITUSSIVE A drug used to relieve coughing ARRHYTHMIA Any change from the normal heartbeat (abnormal heartbeat) ASPIRATION Fluid entering lungs ASSAY Lab test ASSESS To learn about ASTHMA A lung disease associated with tightening of the air passages ASYMPTOMATIC Without symptoms AXILLA Armpit BENIGN Not malignant, usually without serious consequences, but with some exceptions e.g.
    [Show full text]